Related references
Note: Only part of the references are listed.TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
Jumpei Teramachi et al.
HAEMATOLOGICA (2021)
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice
Scott A. Scarneo et al.
ARTHRITIS RESEARCH & THERAPY (2019)
TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
R. K. Subbarao Malireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70
Meng Zhao et al.
NATURE COMMUNICATIONS (2018)
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
C. Guo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
Douglas S. Jones et al.
NATURE CHEMICAL BIOLOGY (2017)
PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo
J. Teramachi et al.
ORAL DISEASES (2017)
Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors
Fredrik Stralberg et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
A Brief History of IL-1 and IL-1 Ra in Rheumatology
Jean-Michel Dayer et al.
FRONTIERS IN PHARMACOLOGY (2017)
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects
Hirofumi Tenshin et al.
BLOOD ADVANCES (2017)
Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3
Masahiro Hiasa et al.
CANCER RESEARCH (2017)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients
Sahar Mahfouz Abdel Galil et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
Zhenyu Wang et al.
SCIENTIFIC REPORTS (2016)
Double Stranded RNA-Dependent Protein Kinase is Necessary for TNF--Induced Osteoclast Formation In Vitro and In Vivo
Hiroki Shinohara et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Activation of TAK1 by Chemotactic and Growth Factors, and Its Impact on Human Neutrophil Signaling and Functional Responses
Stephanie Sylvain-Prevost et al.
JOURNAL OF IMMUNOLOGY (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
Christianna Choulaki et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
TAK1 control of cell death
S. R. Mihaly et al.
CELL DEATH AND DIFFERENTIATION (2014)
Induced production of anti-etanercept antibody in collagen-induced arthritis
Hyoju Yi et al.
MOLECULAR MEDICINE REPORTS (2014)
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
Patty C. H. Cai et al.
ONCOTARGET (2014)
Interleukin 6 and Rheumatoid Arthritis
Yuji Yoshida et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
Jiaquan Wu et al.
ACS CHEMICAL BIOLOGY (2013)
TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis
Betty Lamothe et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
Yu Chen et al.
RHEUMATOLOGY (2013)
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation
Rowan S. Hardy et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Essential role of TAK1 in regulating mantle cell lymphoma survival
Daniela Buglio et al.
BLOOD (2012)
Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide
Takayuki Yamaguchi et al.
INFLAMMATION RESEARCH (2012)
Critical role for calcium mobilization in activation of the NLRP3 inflammasome
Tomohiko Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Managing Macrophages in Rheumatoid Arthritis by Reform or Removal
Jun Li et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Regulation of bone by the adaptive immune system in arthritis
Kazuo Okamoto et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Toll-like Receptor -A Potent Driving Force behind Rheumatoid Arthritis-
Michiaki Takagi
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2011)
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III
Yongchun Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
Bone Damage in Rheumatoid Arthritis: Mechanistic Insights and Approaches to Prevention
Sougata Karmakar et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Rheumatoid arthritis progression mediated by activated synovial fibroblasts
Elena Neumann et al.
TRENDS IN MOLECULAR MEDICINE (2010)
RANK ligand as a therapeutic target for bone metastases and multiple myeloma
G. David Roodman et al.
CANCER TREATMENT REVIEWS (2008)
TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis
A. Safina et al.
ONCOGENE (2008)
Collagen-induced arthritis
David D. Brand et al.
NATURE PROTOCOLS (2007)
Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-κB activation -: TAO2 regulates TAK1 pathways
Wei-Chun HuangFu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Critical role of M-tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice
Hirayasu Kai et al.
IMMUNOLOGY (2006)
Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes
T Inoue et al.
JOURNAL OF IMMUNOLOGY (2005)
The role of interleukin-1 in the pathogenesis of rheumatoid arthritis
J. Kay et al.
RHEUMATOLOGY (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
RN Pearse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
